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INTRODUCTION 
Identifying health priorities is an essential step in 
providing health education programs and changes in 
planning any intervention in the provision of health 
services and health promotion in society. One of these 
priorities is reducing maternal mortality. One of the 
major causes of mortality among pregnant women is pre-
eclampsia, that despite extensive research, the main cause 
of it is unknown. Pre-eclampsia is multifactorial and 
many factors such as high blood pressure, obesity (BMI 
>30), multiple pregnancies, race, ethnicity, socio-
economic factors and genetic predisposition are effective 
in pre-eclampsia occurrence.
1-4
 The prevalence of pre-
eclampsia in pregnancy is 5-8% and its incidence is 
common in nulliparous pregnancy. Suffering from Pre-
eclampsia deal to increase its risk in future pregnancies. 
Severe and earlier pre-eclampsia deal to higher risk of 
pre-eclampsia. In fact occur pre-eclampsia before 30th 
week of pregnancy, increase the risk of its relapse by 
40%. Recent studies pointed to effective infections such 
as cytomegalovirus, Chlamydia, pneumonia and H. pylori 
in the pathogenesis of pre-eclampsia.
2
 In terms of the 
relationship between H.pylori and pre-eclampsia, there 
are important points such as: the prevalence of both 
increases with age and is closely related with the 
economic and social conditions of individuals.
5
 
Therefore, by effective treatment of H. pylori, pre-
eclampsia incidence rate can be reduced and also H.pylori 
can be prevented before pregnancy by screening.
6
 
According to the estimates, about 25-50% of people in 
developed countries and 70% in developing countries are 
infected with H. pylori.
7   
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Low socioeconomic condition, population density and 
poor health indicators in childhood are risk factors for the 
pre-eclampsia occurence.
8
 The evidences has shown that 
H. pylori with high virulence can cause inflammation and 
endothelial damage and also, increases platelet activity 
and thrombus formation in vessels.
9,10
 There are several 
methods to diagnose this infection which some of them 
are invasive procedures that require to biopsy and 
endoscopy and some others are noninvasive such as stool 
tests and unease breath test (UBT).
11-14
 Further 
serological tests are used for screening and these tests are 
not applicable for diagnosis because they have low 
specificity and are not necessarily indicatives of the 
infection.
15
 Stool antigen analysis by ELISA method is 
convenient and cheap.
16
 In stool samples, by PCR-ELISA 
method, there is more sensitivity due to the lack of need 
for live bacilli.
11
 
The aim of this study was to investigate the Relationship 
between H. pylori infection and pre-eclampsia among 
pregnant women in Ardabil. 
METHODS 
In this case-control study, 108 pregnant women with pre-
eclampsia, considering the history and primary evaluation 
of SBP higher than 140 mmHg or DBP higher than 90 
mmHg and positive urine analysis of protein or 24-hour 
urine collection over 300 mg in  24 hours, and 108 
healthy pregnant women were selected.  After obtaining 
consent from all of the samples, they were studied in 
terms of maternal age, gestational age and body mass 
index before and after pregnancy, history of reumatismul 
disease and diabetes, respectively. 5 cc blood samples 
and stool samples obtained from the women. Stool 
samples were taken in plastic containers and sent to the 
laboratory as soon as possible. In case of delay in sending 
the samples, they could be kept at 2 to 8 °C in the 
refrigerator for up to two days and at -20 °C up to one 
month. The samples were measured for antigen rate by H. 
pylori antigen kit (Italy; DIA PR diagnostic) using 
ELISA method, in stool. Based on the kit instruction, 
values equal or higher than 1.1 were considered positive 
and less than 1.1 were considered negative.  5 cc venous 
blood sample was taken from each patient and was 
poured in tubes containing EDTA. The samples shouldn't 
heparinized or citrated. The samples could be kept in 
refrigerator for up to fourteen days at +2 to +4 °C and at -
30 °C for a long time. When analyzing, the samples were 
located in a centrifuge for 5 minutes with 400 laps. The 
separated serum diluted with 1:101 dilutions, then the 
samples by ELISA method and DYNEX set were studied. 
The Cag A antigen, an indicator of a highly virulent 
strain of H. pylori. The set's calibration was performed by 
specifications in the kit brochure. Kit (anti Helicobacter 
Cag A ELISA IgG) was the product of Euro Immun U.K. 
company with serial number order NOE 12081-9601 G. 
The results were divided into three categories. The 
answers higher than or equal to 22 U/Ml was considered 
positive and less than 5 U/Ml negative. The rest of the 
answers were considered intermediate between these two 
periods. The information taken from the checklists along 
with information from blood and stool samples from the 
cases was analyzed in SPSS 21 using descriptive and 
inferential statistical methods. 
RESULTS 
Pregnant women with pre-eclampsia were similar with 
the control group in terms of age, incidence of diabetes, 
history of disease and smoking. 7% of women in the 
preeclampsia group and 12% in the control group were 
taking aspirin. Epigastric pain during pregnancy was seen 
in 22% of women in preeclampsia group and 37% of 
women in the control group. In women with pre-
eclampsia, the rate of positivity for Cag A in laboratory 
testing with 27.8% was lower than the control group with 
31.4% but the differences between two groups was not 
statistically significant as given in Table 1. Percentage of 
positivity of H. pylori stool antigen test in women with 
pre-eclampsia with 62% significantly was more than 
women in control group with 44% as shown in Table 2.  
The chance of exposure to H. pylori in women with pre-
eclampsia, based on stool serology tests, was 1.8 times 
more than the chance of exposure to H. pylori in healthy 
women (control group). The rate of infants with low birth 
weight (LBW) in women with pre-eclampsia with 38.5% 
was significantly more than the healthy women with 8% 
as shown in Table 3. In the case group in which the result 
of serology stool was positive, 33.6%, and in the control 
group 57.4% of infants have LBW and the difference was 
not statistically significant as in Table 4. 
Table 1: Result of CAG A test between two groups. 
Group 
Cag A 
Women with 
pre-eclampsia 
Control 
P value 
n % n % 
Postive 30 27.8 43                           31.4 
0.33 
Negative 78 72.2 43 68.6 
Table 2: Result of stool antigen test between two 
groups. 
Group 
Cag A 
Women with 
pre-eclampsia 
Control 
P value 
n % n % 
Postive 74 76 34 44.4 
0.001 
Negative 34 44 76 55.6 
Table 3: Low birth weight rate between two groups. 
Group 
LBW 
Women with 
pre-eclampsia 
Control 
p.value 
n % n % 
Postive 36 37 4 6.5 
0.001 
Negative 74 63 466 93.5 
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Table 4: Frequency of LBW by result of serology in 
two groups. 
Group Serology 
Test 
results  
LBW  P 
value + - 
Women with 
pre-eclampsia 
Positive  33.6 66.4 0.82 
Negative  57.4 42.6 
Control  Positive  55.6 44.4 0.28 
Negative  44.4 55.6 
DISCUSSION 
In this study, although Cag A positive antigen was in 30 
(27.8%) women with pre-eclampsia and 34 (31.4%) 
women in the control group, but no significant 
relationship was observed between them. But in terms of 
the stool antigen test, 67 patients (62%) in the case group 
and 48 patients (44.4%) were positive in the control 
group that was statistically significant result.  
In a study conducted by UstUn et al in which serum 
antigen Cag A was studied, there was a significant 
relationship between infection and pre-eclampsia.
5
 In 
Ponzettoa et al study,   Cag A positivity serology in 47 
mothers with pre-eclampsia (51.1%) was compared with 
47 pregnant women without complications (31.9%) that 
this relationship was not statistically significant.
1
 
In a study conducted by Cardaropoli et al about the 
relationship between H. pylori infection and its 
association with pre-eclampsia and low fetal growth, 
results showed that H. pylori is associated with 
preeclampsia and low growth of fetal.
15
 
In Bagheri et al study, the rate of  the positive serum 
against H. pylori infection in women suffering from pre-
eclampsia was higher than the control group but this was 
not statistically significant.
16
 In this study, the number of 
samples that were higher than similar studies and 
according to the serologically  in line studies in which the 
number of samples were more, It seems that the more 
number of samples, the less relationship between 
serology positivity Helicobacter pylori and pre-
eclampsia. On the other hand, the relationship accuracy 
increases and this can be more closely linked to the high 
prevalence of infection in our study area. Generally, 
differences in study design, prevalence of H. pylori in 
different geographical areas, social and economic 
differences, diet, number of studied samples, comparison 
of the results and the most important issue, was the 
mechanism of different factors affect in suffering from 
pre-eclampsia.
6,17-19
 
CONCLUSION 
The results showed that the chance of exposure to H. 
pylori in women with pre-eclampsia based on stool 
serology tests is 1.8 times significantly more than the 
chance of exposure to H. pylori in healthy women. In 
comparing the pre-eclampsia fetal complications among 
the pre-eclampsia women with positive H. pylori, the 
frequency of low birth weight infants in the control group 
was higher than the other group but among women in the 
control group, with positive infection and healthy women 
individuals this relationship was not significant. 
Therefore, considering the relationship between positive 
stool test and preeclampsia occurrence we can use 
screening for high risk women and treatment for pre-
eclampsia women.  
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